Treatment with JAK inhibitors was associated with a greater risk of infections compared with biologic therapies in patients with atopic dermatitis.

The risk for COVID-19-related hospitalization was not significantly different between vaccinated older adults with vs without age-restrictive access to nirmatrelvir-ritonavir.

Michael Rogers, associate commissioner for inspections and investigations at the US FDA, announced his decision to retire.

Metformin use in patients with HIV and type 2 diabetes who had at least 2 years of exposure to effective ART showed no significant effect on immune reconstitution.

From 2006 to 2019, age-adjusted mortality for liver disease in the US increased by 14% overall and by 24% during COVID, from 2019 through 2021.

North Dakota is the latest state to find itself dealing with a measles outbreak, becoming the 11th state in the nation to face the challenge.

A quality improvement program can improve recommended antibiotic duration in children for acute otitis media and community-acquired pneumonia.

The United States Food and Drug Administration has chosen Dr Vinay Prasad to lead its Center for Biologics Evaluation and Research.